The broader indices have demonstrated strong performance in August, with smallcaps significantly outperforming the benchmark indices. According to reports from Business Standard, the Nifty SmallCap, Nifty SmallCap 50 and Nifty SmallCap 250 have surged over 3 per cent each, while the Nifty Midcap and Nifty MidCap 150 advanced over 1 per cent each. In contrast, the Nifty 50 index was down 0.5 per cent this month. V K Vijayakumar, Chief Investment Strategist at Geojit Investments, noted that companies reporting good results and forward guidance are being bought by both retail and institutional investors at high valuations, with the sharp rally attributed to limited floating stocks in most broader market stocks.
Pabitro Mukherjee, Deputy Vice President - Technical at Bajaj Broking, identifies Engineers India as positioned for a breakout above a bullish 'Cup and Handle' formation on the weekly chart. According to the technical analysis reported by Business Standard, the analyst sets a buy range of ₹240-245 with a target price of ₹265 and stop loss at ₹228 for a 3-month time horizon. The base of the consolidation pattern was placed at the 52-week Exponential Moving Average (EMA), signalling strength and positive bias. Mukherjee expects the stock to head toward ₹265, which was the high of May and June 2026, with immediate support at ₹230-235 levels.
For Sagility, Mukherjee recommends a buy range of ₹42-43.50 with a target price of ₹47 and stop loss at ₹40 for a 3-month time horizon. As reported by Business Standard, the technical outlook shows the stock at the cusp of generating a breakout above a bullish 'Cup and Handle' formation. The weekly 14-period Relative Strength Index (RSI) generated a 'Buy' signal after moving above its 9-period average, which validates the positive bias. The analyst expects the stock to move toward the target price of ₹47, with immediate support identified at ₹40 levels.
Black Rose Industries delivered robust FY26 results with revenue growing 4.3% to ₹323 crore and profit after tax rising 7%, demonstrating strong operational performance across its chemical manufacturing business. The company's capital employed increased 3.64% to ₹166.50 crore while net worth rose 10.90% to ₹169.28 crore, reflecting retained profits and strategic investments. The manufacturing business remained the primary profitability driver, with acrylamide liquid volumes registering healthy growth driven by strong domestic demand and export market acceptance. The N-Methylol Acrylamide (NMA) business delivered outstanding performance with sales volumes nearly doubling over the previous year due to higher offtakes from key customers and new additions.
